|
|
||||
![]() | ||||
|
|
|
Select from the search options to widen or narrow the search results.
The purpose of this study is to find out if oral treatment with a new study medication can decrease the number of MS relapses during a certain time period. Participants must:
For more information, please contact Tayo Olapo at 414-385-1805 or tayo.olapo@aurora.org Principal Investigator, Bhupendra Khatri, MD Clinical trial location(s)Aurora St. Luke's Medical Center2900 West Oklahoma Avenue Milwaukee, WI 53215 Private Physician's Office
[ previous page ]
|
||
|
|
|
|||